March 9, 2020 / 4:45 PM / 25 days ago

BRIEF-HHS Supports Development Of First High-Throughput Covid-19 Diagnostic Test

March 9 (Reuters) - Hologic Inc:

* HHS Supports Development Of First High-Throughput Covid-19 Diagnostic Test

* HHS - HOLOGIC’S MOLECULAR DIAGNOSTIC TEST BECOMES FIRST COVID-19 PRODUCT SELECTED FOR DEVELOPMENT THROUGH ASPR’S STREAMLINED SELECTION PROCESS

* HHS - BARDA TO CONTRIBUTE $699,000 TO ACCELERATE HOLOGIC’S DEVELOPMENT OF TEST THAT DETECTS GENETIC MATERIAL OF SARS-COV-2, VIRUS THAT CAUSES COVID-19

* HHS SAYS THE MOLECULAR DIAGNOSTIC TEST RESULTS COULD BE AVAILABLE TO CLINICIANS IN LESS THAN THREE HOURS

* HHS - MOLECULAR DIAGNOSTIC TEST FROM HOLOGIC WILL BE DESIGNED FOR USE WITH HOLOGIC’S PANTHER FUSION SYSTEM

* HHS- BARDA & HOLOGIC EXPECT NECESSARY DEVELOPMENT IN WEEKS THAT WOULD ALLOW FDA TO CONSIDER GRANTING EMERGENCY USE AUTHORIZATION FOR DIAGNOSTIC TEST Source text: (bit.ly/2wJEGsw) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below